We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The International Trade Commission (ITC) decided not to review its administrative law judge's decision to terminate the investigation of the importation of C.E.R.A. (Continuous Erythropoietin Receptor Activator) into the United States, Roche announced.
Sanofi pasteur, a subsidiary of French drugmaker sanofi-aventis, has begun shipping its influenza vaccine, Fluzone, to the U.S. for the 2006-2007 flu season.
Toray Industries, Japan Tobacco and Torii Pharmaceutical have announced an agreement to jointly develop and market a novel antipruritic (anti-itch) agent, TRK-820, discovered by Toray, for liver disease patients in Japan.
The biotechnology company MediGene AG announced today that it has signed an agreement on the acquisition of the privately held biotechnology company Avidex Ltd. based in Oxford, UK.
In the first drug master file (DMF) approval of its kind, the US Food and Drug Administration (FDA) has approved the sale of metformin hydrochloride tablets which are produced by an Indian company using a pharmaceutical formulation intermediate (PFI), an alternative to sourcing active pharmaceutical ingredients (APIs) which could revolutionalise the conventional pharmaceutical manufacturing model.
The Fukuoka District Court ordered the state and drug companies Wednesday to pay a combined 168 million yen in damages to 11 of 18 people infected with the hepatitis C virus from tainted blood products.
Sanofi-aventis and Bristol-Myers Squibb (the "companies") today announced that the U.S. District Court for the Southern District of New York has granted a preliminary injunction ordering Apotex Inc. and Apotex Corp. ("Apotex") to halt its sales of a generic version of clopidogrel bisulfate product that competes with PLAVIX.